UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A review of current evidence for acetyl- l -carnitine in the treatment of depression

Journal of psychiatric research, 2014-06, Vol.53, p.30-37

2014

Volltextzugriff (PDF)

Investigating the effectiveness of a smart mental health intervention (inMind) for stress reduction during pharmacological treatment for mild to moderate major depressive disorders: Study protocol for a randomized control trial

Frontiers in psychiatry, 2023-03, Vol.14, p.1034246-1034246

2023

Volltextzugriff (PDF)

Modafinil for the treatment of Attention-deficit/hyperactivity disorder: a meta-analysis

Journal of psychiatric research, 2017-01, Vol.84, p.292-300

2017

Volltextzugriff (PDF)

Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder

Journal of psychiatry & neuroscience, 2015-05, Vol.40 (3), p.174-186

2015

Volltextzugriff (PDF)

Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?

Clinical Psychopharmacology and Neuroscience, 2021, 19(3), , pp.434-448

2021

Volltextzugriff (PDF)

Preclinical pharmacology of amphetamine: Implications for the treatment of neuropsychiatric disorders

Pharmacology & therapeutics (Oxford), 2014-09, Vol.143 (3), p.253-264

2014

Volltextzugriff (PDF)

Effect of Frailty on Depression among Patients with Late-life Depression: A Test of Anger, Anxiety, and Resilience as Mediators

Clinical Psychopharmacology and Neuroscience, 2024, 22(2), , pp.253-262

2024

Volltextzugriff (PDF)

A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders

PloS one, 2017-06, Vol.12 (6), p.e0179247-e0179247

2017

Volltextzugriff (PDF)

Sensitivity of cognitive tests in four cognitive domains in discriminating MDD patients from healthy controls: a meta-analysis

International psychogeriatrics, 2013-09, Vol.25 (9), p.1543-1557

2013

Volltextzugriff (PDF)

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study

PSYCHIATRY INVESTIGATION, 2022, 19(4), , pp.268-280

2022

Volltextzugriff (PDF)

The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting

Clinical Psychopharmacology and Neuroscience, 2024, 22(2), , pp.370-375

2024

Volltextzugriff (PDF)

Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting

Clinical Psychopharmacology and Neuroscience, 2023, 21(3), , pp.594-598

2023

Volltextzugriff (PDF)

Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia

Clinical Psychopharmacology and Neuroscience, 2021, 19(4), , pp.600-609

2021

Volltextzugriff (PDF)

Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study

Psychopharmacologia, 2009-10, Vol.206 (3), p.479-489

2009

Volltextzugriff (PDF)

Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder

Clinical Psychopharmacology and Neuroscience, 2021, 19(2), , pp.243-253

2021

Volltextzugriff (PDF)

Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study

Clinical Psychopharmacology and Neuroscience, 2021, 19(2), , pp.233-242

2021

Volltextzugriff (PDF)

The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective Study

Clinical Psychopharmacology and Neuroscience, 2019, 17(4), , pp.495-502

2019

Volltextzugriff (PDF)

Prescription Pain Reliever Abuse and Dependence Among Adolescents: A Nationally Representative Study

Journal of the American Academy of Child and Adolescent Psychiatry, 2008-09, Vol.47 (9), p.1020-1029

2008

Volltextzugriff (PDF)

Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study

Clinical Psychopharmacology and Neuroscience, 2020, 18(1), , pp.153-158

2020

Volltextzugriff (PDF)

Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1

Clinical Psychopharmacology and Neuroscience, 2019, 17(3), , pp.364-368

2019

Volltextzugriff (PDF)

Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial

Clinical Psychopharmacology and Neuroscience, 2020, 18(4), , pp.641-641

2020

Volltextzugriff (PDF)

A Randomized, Controlled, Trial of Controlled Release Paroxetine in Fibromyalgia

The American journal of medicine, 2007-05, Vol.120 (5), p.448-454

2007

Volltextzugriff (PDF)

The Genetic Determinants of Smoking

Chest, 2003-05, Vol.123 (5), p.1730-1739

2003

Volltextzugriff (PDF)

The influence of AHI1 variants on the diagnosis and treatment outcome in schizophrenia

International journal of molecular sciences, 2015-01, Vol.16 (2), p.2517-2529

2015

Volltextzugriff (PDF)

Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants

Progress in neuro-psychopharmacology & biological psychiatry, 2013-10, Vol.46, p.224-235

2013

Volltextzugriff (PDF)

1 – 25 von 383

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(353)
Mit Volltextzugriff
(291)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(267)
Life Sciences & Biomedicine
(258)
Humans
(218)
Psychiatry
(138)
Female
(134)
Male
(133)
Adult
(121)
Pharmacology & Pharmacy
(96)
Neurosciences & Neurology
(92)
Biological And Medical Sciences
(87)
Medical Sciences
(87)
Middle Aged
(74)
Psychology. Psychoanalysis. Psychiatry
(71)
Psychopathology. Psychiatry
(67)
Neurosciences
(65)
Treatment Outcome
(64)
Adult And Adolescent Clinical Studies
(61)
Clinical Neurology
(54)
Substance Abuse
(53)
Depression
(49)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A review of current evidence for acetyl- l -carnitine in the treatment of depression

Investigating the effectiveness of a smart mental health intervention (inMind) for stress reduction during pharmacological treatment for mild to moderate major depressive disorders: Study protocol for a randomized control trial

Modafinil for the treatment of Attention-deficit/hyperactivity disorder: a meta-analysis

Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder

Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?

Preclinical pharmacology of amphetamine: Implications for the treatment of neuropsychiatric disorders

Effect of Frailty on Depression among Patients with Late-life Depression: A Test of Anger, Anxiety, and Resilience as Mediators

A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders

Sensitivity of cognitive tests in four cognitive domains in discriminating MDD patients from healthy controls: a meta-analysis

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study

The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting

Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting

Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia

Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study

Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder

Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study

The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective Study

Prescription Pain Reliever Abuse and Dependence Among Adolescents: A Nationally Representative Study

Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study

Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1

Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial

A Randomized, Controlled, Trial of Controlled Release Paroxetine in Fibromyalgia

The Genetic Determinants of Smoking

The influence of AHI1 variants on the diagnosis and treatment outcome in schizophrenia

Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants

Suchergebnisse filtern